Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Product approval in US

7 Feb 2008 07:00

ViaLogy PLC07 February 2008 VIALOGY SPM product successfully tested and approved by US National Incident Management System London, 7 February, 2008: ViaLogy PLC (LSE: VIY), a leading innovator ofreal-time network-centric signal processing platforms, announces that itsproduct SPMTM (Sensor Policy ManagerTM), for sensor interoperability andintegration, has received unqualified approval from America's National IncidentManagement System Support Center (NIMS SC), a division of The Department ofHomeland Security's (DHS) Federal Emergency Management Agency (FEMA). NIMSawarded SPM top marks in all tested categories. NIMS has been established by the US government to deal with national emergencysituations, including terrorist attacks. It enables responders from differentjurisdictions and disciplines to work together to respond to natural disastersand emergencies, including acts of terrorism. Benefits include a unifiedapproach to incident management; standard command and management structures; andemphasis on preparedness, mutual aid and resource management. Key to any emergency situation response is the ability of all the differentsensors involved to integrate information and prioritise alerts. ViaLogy's SPMis designed specifically to enable this to happen seamlessly and immediately. Inrecent weeks NIMS engineers have been subjecting the product to extensive andrigorous testing. They have determined that SPM meets all its requiredstandards. "The product is consistent with the concepts and principles of NIMS,"concludes the Evaluation Report. "It is applicable to all 15 Emergency SupportFunctions, all six hazard groups, and to a multi-jurisdictional response." Ineach case the tests marked SPM five out of five. In addition, the report praisedthe speed at which SPM could be incorporated in any sensor and the fact that ittakes just 20 hours to fully train an SPM operator. "We are absolutely delighted with the NIMS validation," said Robert W. Dean,President and CEO of ViaLogy. "Our SPM product is designed to enable aco-ordinated proactive response by all the emergency services involved indealing with an emergency incident. Quite simply, it will help to save lives. "Most importantly, the system is sensor agnostic so it can create instantcommunication between a wide variety of sensors used in a range of safety,security and emergency response applications." ViaLogy is also participating in additional validation demonstrations with anumber of manufacturers involved in producing and integrating commercialsecurity systems. ends ViaLogyRobert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0)1235 834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0)20 7107 8000 PR Consultants - Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defense and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Aug 202310:32 amRNSForm 8.3 - Yourgene Health PLC
1st Aug 20239:23 amRNSForm 8.5 (EPT/RI)
31st Jul 202310:59 amRNSForm 8.3 - Yourgene Health PLC
31st Jul 20239:38 amRNSForm 8.5 (EPT/RI)
28th Jul 202310:53 amRNSForm 8.5 (EPT/RI)
27th Jul 20237:00 amRNSPublication of Scheme Document & current trading
26th Jul 20234:45 pmRNSForm 8.3 - Yourgene Health plc
26th Jul 202310:12 amRNSForm 8.5 (EPT/RI)
26th Jul 20238:45 amRNSForm 8.3 - YOURGENE HEALTH PLC
26th Jul 20237:00 amRNSFive-year contract extension with Illumina
25th Jul 20232:06 pmRNSForm 8.3 - Yourgene Health plc
25th Jul 20239:48 amRNSForm 8.5 (EPT/RI) - Yourgene Health PLC
25th Jul 20237:00 amRNSForm 8.3 - Yourgene Health Plc
24th Jul 20238:32 amRNSForm 8.3 - Yourgene Health PLC
21st Jul 20238:59 amRNSForm 8.5 (EPT/RI)
20th Jul 202311:44 amRNSForm 8.5 (EPT/RI)
19th Jul 20232:06 pmRNSForm 8.3 - Yourgene Health plc
19th Jul 202312:21 pmRNSRule 2.9 Announcement
19th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
19th Jul 20237:00 amRNSIssue of equity, cancellation of warrants & TVR
18th Jul 20235:15 pmRNSForm 8.5 (EPT/RI) Replacement - Yourgene Health PL
18th Jul 20235:13 pmRNSForm 8.3 - YourGene Health plc
18th Jul 20235:00 pmRNSForm 8.5 (EPT/RI) Replacement
18th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
18th Jul 20238:39 amRNSForm 8.3 - Yourgene Health PLC
17th Jul 20235:00 pmRNSForm 8.3 - Yourgene Health Plc
17th Jul 202312:00 pmRNSForm 8.5 (EPT/RI)
17th Jul 202310:27 amRNSForm 8.5 (EPT/RI)
17th Jul 20239:05 amRNSForm 8.3 - Yourgene Health PLC
17th Jul 20238:15 amRNSForm 8.3 - YOURGENE HEALTH PLC
14th Jul 20232:02 pmRNSForm 8.3 - Yourgene Health plc
14th Jul 202312:02 pmRNSForm 8.5 (EPT/RI)
14th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
14th Jul 202310:36 amRNSForm 8.3 - YOURGENE HEALTH PLC
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
13th Jul 20234:29 pmRNSForm 8 (OPD) (Yourgene Health Plc)
13th Jul 20232:03 pmRNSForm 8.3 - Yourgene Health plc
13th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 202310:43 amRNSForm 8.3 - Yourgene Health Plc
13th Jul 202310:17 amRNSForm 8.5 (EPT/RI)
13th Jul 20239:02 amRNSForm 8.3 - Yourgene Health PLC
13th Jul 20238:53 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20232:04 pmRNSForm 8.3 - Yourgene Health plc
12th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
12th Jul 202311:39 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20239:21 amRNSForm 8.5 (EPT/RI)
12th Jul 20238:44 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20238:18 amRNSForm 8.3 - Yourgene Health PLC
11th Jul 20232:20 pmRNSForm 8.3 - Yourgene Health plc
11th Jul 202312:46 pmRNSForm 8.3 - Yourgene Health PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.